Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. Phillip Louis Gomez III, M.D., Ph.D. |
IPO Date | Sept. 9, 1997 |
Location | United States |
Headquarters | 31 East 62nd Street, New York, NY, United States, 10065 |
Employees | 45 |
Sector | Healthcare |
Industry | Drug manufacturers - specialty & generic |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
NA
NA
StockViz Staff
September 20, 2024
Any question? Send us an email